Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.

Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT, Hommer D, Barr CS.

Neurosci Biobehav Rev. 2010 Nov;35(2):334-44. doi: 10.1016/j.neubiorev.2009.11.018. Epub 2009 Nov 24. Review.

PMID:
19941895
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context.

Marinelli PW, Funk D, Harding S, Li Z, Juzytsch W, Lê AD.

Eur J Neurosci. 2009 Aug;30(4):671-8. doi: 10.1111/j.1460-9568.2009.06851.x. Epub 2009 Aug 3.

PMID:
19686472
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake.

van Rijn RM, Whistler JL.

Biol Psychiatry. 2009 Oct 15;66(8):777-84. doi: 10.1016/j.biopsych.2009.05.019. Epub 2009 Jul 3.

PMID:
19576572
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pharmacogenetics of anxiolytic drugs.

Tiwari AK, Souza RP, Müller DJ.

J Neural Transm. 2009 Jun;116(6):667-77. doi: 10.1007/s00702-009-0229-6. Epub 2009 May 12. Review.

PMID:
19434367
[PubMed - indexed for MEDLINE]
5.

Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala.

Bie B, Zhu W, Pan ZZ.

Neuroscience. 2009 May 5;160(2):348-58. doi: 10.1016/j.neuroscience.2009.02.049. Epub 2009 Mar 1.

PMID:
19258026
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Current use of benzodiazepines in anxiety disorders.

Cloos JM, Ferreira V.

Curr Opin Psychiatry. 2009 Jan;22(1):90-5. doi: 10.1097/YCO.0b013e32831a473d. Review.

PMID:
19122540
[PubMed - indexed for MEDLINE]
7.

The state of pharmacotherapy for the treatment of alcohol dependence.

Garbutt JC.

J Subst Abuse Treat. 2009 Jan;36(1):S15-23; quiz S24-5. Review.

PMID:
19062347
[PubMed - indexed for MEDLINE]
8.

Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption.

Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM.

J Neurosci. 2008 Nov 26;28(48):12672-81. doi: 10.1523/JNEUROSCI.4569-08.2008.

PMID:
19036960
[PubMed - indexed for MEDLINE]
Free Article
9.

Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol.

Mitchell JM, Bergren LJ, Chen KS, Rowbotham MC, Fields HL.

Neurobiol Dis. 2009 Jan;33(1):72-80. doi: 10.1016/j.nbd.2008.09.018. Epub 2008 Oct 1.

PMID:
18955144
[PubMed - indexed for MEDLINE]
10.

Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice.

Lalonde R, Strazielle C.

J Neurosci Methods. 2008 Jun 15;171(1):48-52. doi: 10.1016/j.jneumeth.2008.02.003. Epub 2008 Feb 12.

PMID:
18358538
[PubMed - indexed for MEDLINE]
11.

Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.

George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M.

Science. 2008 Mar 14;319(5869):1536-9. doi: 10.1126/science.1153813. Epub 2008 Feb 14.

PMID:
18276852
[PubMed - indexed for MEDLINE]
Free Article
12.

The alcohol withdrawal syndrome.

McKeon A, Frye MA, Delanty N.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):854-62. Epub 2007 Nov 6. Review.

PMID:
17986499
[PubMed - indexed for MEDLINE]
13.

Emerging approaches to managing alcohol dependence.

Swift R.

Am J Health Syst Pharm. 2007 Mar 1;64(5 Suppl 3):S12-22. Review. Erratum in: Am J Health Syst Pharm. 2007 Apr 15;64(8):803.

PMID:
17322178
[PubMed - indexed for MEDLINE]
14.

Human and economic burden of generalized anxiety disorder.

Hoffman DL, Dukes EM, Wittchen HU.

Depress Anxiety. 2008;25(1):72-90. Review.

PMID:
17146763
[PubMed - indexed for MEDLINE]
15.

The role of delta opioid receptors in the anxiolytic actions of benzodiazepines.

Primeaux SD, Wilson SP, McDonald AJ, Mascagni F, Wilson MA.

Pharmacol Biochem Behav. 2006 Nov;85(3):545-54. Epub 2006 Nov 15.

PMID:
17109943
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
[PubMed - indexed for MEDLINE]
17.

Naltrexone renders one-session exposure therapy less effective: a controlled pilot study.

Kozak AT, Spates CR, McChargue DE, Bailey KC, Schneider KL, Liepman MR.

J Anxiety Disord. 2007;21(1):142-52. Epub 2006 May 2.

PMID:
16647240
[PubMed - indexed for MEDLINE]
18.

Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.

Perrine SA, Hoshaw BA, Unterwald EM.

Br J Pharmacol. 2006 Apr;147(8):864-72.

PMID:
16491101
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacotherapy of alcohol use disorders.

Buonopane A, Petrakis IL.

Subst Use Misuse. 2005;40(13-14):2001-20, 2043-8. Review.

PMID:
16282090
[PubMed - indexed for MEDLINE]
20.

Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.

Saitoh A, Yoshikawa Y, Onodera K, Kamei J.

Psychopharmacology (Berl). 2005 Nov;182(3):327-34. Epub 2005 Oct 19.

PMID:
16075288
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk